• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重型 α 地中海贫血——新突变、宫内管理和结局。

Alpha thalassemia major--new mutations, intrauterine management, and outcomes.

机构信息

Children's Hospital & Research Center Oakland, Oakland, CA 94609, USA.

出版信息

Hematology Am Soc Hematol Educ Program. 2009:35-41. doi: 10.1182/asheducation-2009.1.35.

DOI:10.1182/asheducation-2009.1.35
PMID:20008180
Abstract

Alpha thalassemia disorders are a group of hereditary anemias caused by absent or decreased production of the alpha chain of hemoglobin. Hemoglobin Bart's hydrops fetalis is usually a fatal in-utero disease caused by absence of the alpha genes. However, the molecular and genotypic expression of hemoglobin Bart's varies and increasing numbers of births are being reported. Population screening and prenatal diagnosis of at-risk couples is essential but often not performed. Most affected pregnancies are often undetected, resulting in severe fetal and maternal complications. Noninvasive monitoring by Doppler ultrasonagraphy with intrauterine transfusion therapy has changed the prognosis for this disorder. These advances in intrauterine and postnatal therapy have resulted in ethical dilemmas for the family and the provider.

摘要

阿尔法地中海贫血症是一组由血红蛋白阿尔法链缺失或减少引起的遗传性贫血症。血红蛋白 Bart's 胎儿水肿症通常是一种致命的宫内疾病,由阿尔法基因缺失引起。然而,血红蛋白 Bart's 的分子和基因型表达存在差异,越来越多的病例被报道。对高危夫妇进行人群筛查和产前诊断至关重要,但往往未得到实施。大多数受影响的妊娠通常未被发现,导致严重的胎儿和母体并发症。多普勒超声检查结合宫内输血治疗的非侵入性监测改变了这种疾病的预后。这些宫内和产后治疗的进展给家庭和医疗服务提供者带来了伦理困境。

相似文献

1
Alpha thalassemia major--new mutations, intrauterine management, and outcomes.重型 α 地中海贫血——新突变、宫内管理和结局。
Hematology Am Soc Hematol Educ Program. 2009:35-41. doi: 10.1182/asheducation-2009.1.35.
2
Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system.在日常实践中使用双重检查聚合酶链反应系统对巴氏水肿胎儿血红蛋白进行准确的产前诊断。
Acta Haematol. 2009;121(4):227-33. doi: 10.1159/000225930. Epub 2009 Jun 19.
3
Treatment of alpha(0)-thalassemia (--(SEA)/--(SEA)) via serial fetal and post-natal transfusions: Can early fetal intervention improve outcomes?通过系列胎儿期和出生后输血治疗α(0)地中海贫血(--(SEA)/--(SEA)):早期胎儿干预能否改善结局?
Hematology. 2015 May;20(4):217-22. doi: 10.1179/1607845414Y.0000000187. Epub 2014 Aug 12.
4
Characterization of Hb Bart's Hydrops Fetalis Caused by - - and a Large Novel α-Thalassemia Deletion.由--和一个大型新型α地中海贫血缺失导致的巴氏水肿胎儿血红蛋白的特征分析
Hemoglobin. 2018 Jan;42(1):61-64. doi: 10.1080/03630269.2018.1434198. Epub 2018 Mar 1.
5
Simplified PGD of common determinants of haemoglobin Bart's hydrops fetalis syndrome using multiplex-microsatellite PCR.多重微卫星 PCR 简化血红蛋白 Bart's 水肿胎儿综合征常见决定因素的 PGD。
Reprod Biomed Online. 2010 Nov;21(5):642-8. doi: 10.1016/j.rbmo.2010.06.021. Epub 2010 Jun 19.
6
Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening.β地中海贫血携带者中α地中海贫血的检测及通过产前筛查预防巴氏水肿胎儿
Haematologica. 2006 May;91(5):649-51.
7
Prenatal diagnosis of Hb Bart's hydrops fetalis caused by a genetic compound heterozygosity for two different alpha-thalassemia determinants.因两种不同α地中海贫血决定簇的遗传复合杂合性导致的血红蛋白Bart胎儿水肿综合征的产前诊断。
Fetal Diagn Ther. 2007;22(4):264-8. doi: 10.1159/000100787. Epub 2007 Mar 16.
8
Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy.复杂性α 地中海贫血:新的筛查、诊断和治疗方法带来的日益严重的健康问题。
Ann N Y Acad Sci. 2010 Aug;1202:180-7. doi: 10.1111/j.1749-6632.2010.05572.x.
9
Diversity in clinical presentation of hemoglobin H disease induced by the SEA deletion and the hemoglobin Quong Sze.由SEA缺失和血红蛋白Quong Sze引起的血红蛋白H病临床表现的多样性。
Ann Hematol. 2009 Nov;88(11):1145-7. doi: 10.1007/s00277-009-0716-8. Epub 2009 Mar 4.
10
Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis.α地中海贫血:血红蛋白H病和血红蛋白巴氏水肿胎儿。
Ann N Y Acad Sci. 2005;1054:25-32. doi: 10.1196/annals.1345.004.

引用本文的文献

1
An analysis of the distribution and spectrum of alpha thalassemia mutations in Rasht City, North of Iran.伊朗北部拉什特市α地中海贫血突变的分布与谱系分析
Front Pediatr. 2023 Mar 22;11:1039148. doi: 10.3389/fped.2023.1039148. eCollection 2023.
2
Methaemalbumin: a diagnostic surrogate for methaemoglobinaemia and treatment with red cell exchange in a patient with thalassaemia.正铁白蛋白:用于诊断高铁血红蛋白血症的替代指标和用于治疗地中海贫血患者的红细胞交换治疗。
BMJ Case Rep. 2023 Mar 7;16(3):e252885. doi: 10.1136/bcr-2022-252885.
3
The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry.
宫内输血对重型 α 地中海贫血患者围产结局的影响:旧金山加利福尼亚大学登记处研究。
Blood Adv. 2023 Jan 24;7(2):269-279. doi: 10.1182/bloodadvances.2022007823.
4
The need to perform α-thalassemia genetic testing in Italian patients with β-thalassemia trait: A case report.对意大利β地中海贫血特征患者进行α地中海贫血基因检测的必要性:一例报告。
Clin Case Rep. 2022 Sep 19;10(9):e6340. doi: 10.1002/ccr3.6340. eCollection 2022 Sep.
5
Genotype-phenotype correlation in patients with deletional and nondeletional mutations of Hb H disease in Southwest of Iran.伊朗西南部缺失型和非缺失型血红蛋白 H 病患者基因突变与表型的相关性研究。
Sci Rep. 2022 Mar 22;12(1):4856. doi: 10.1038/s41598-022-08986-4.
6
Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia.α-和β-地中海贫血症的携带者筛查和产前诊断的最佳策略。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):607-613. doi: 10.1182/hematology.2021000296.
7
The transfusion management of beta thalassemia in the United States.美国β地中海贫血的输血管理
Transfusion. 2021 Oct;61(10):3027-3039. doi: 10.1111/trf.16640. Epub 2021 Aug 28.
8
Challenges in chronic transfusion for patients with thalassemia.地中海贫血患者慢性输血面临的挑战。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):160-166. doi: 10.1182/hematology.2020000102.
9
Perinatal Management of Bart's Hemoglobinopathy: Paradoxical Effects of Intrauterine, Transplacental, and Partial Exchange Transfusions.巴氏血红蛋白病的围产期管理:宫内输血、经胎盘输血和部分换血输血的矛盾效应
AJP Rep. 2020 Jan;10(1):e11-e14. doi: 10.1055/s-0039-3401799. Epub 2020 Jan 27.
10
Biomaterials in fetal surgery.胎儿手术中的生物材料。
Biomater Sci. 2019 Aug 1;7(8):3092-3109. doi: 10.1039/c9bm00177h. Epub 2019 May 17.